On the histochemistry of riboflavin the fluorescence microscopic method using its primary fluorenscence was first reported by Hirt and Wimmer (1, 2, 3) . Thereafter a few papers concerning this field have been published (4, 5, 6 ). In my laboratory, a method combining the lumiflavin fluorescence with the riboflavin fluorescence has been devised (7, 8, 9, 10) . Using this method, the detailed distribution of riboflavin in the body and its fate have been studied. In this method, however, the fluorescence of three kinds of riboflavin in tissues, i.e., free riboflavin (FR), flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which have different fluorescence intensities, are estimated as a whole. FAD, which is present predominantly in the tissues and shows a fluorescence definitely less intense than FR and FMN, is estima ted to be far less than other forms.
Our final aim is, of course, to clarify the distribution of the three forms of the vitamin in the tissues.
As the first step, we have devised a method, enabling to separate the esterified forms from the free one.
The esterified forms are then converted to the free from, the fluorescence of which is then observed.
Using this method, the distribution of the free and esterified ribo flavin in various orgnas in normal rats and those poisoned with carbontetra chloride were studied. TECHNIQUE
Principle
Each form of riboflavin shows a similar yellowish green fluorescence, but there is a definite difference between free riboflavin and the esterified forms in the partition coefficient between benzyl alcohol (BzOH) and water (11, 12) . This property was applied to our histochemical procedure. Bessey (13) reported that the fluorescence energy of one molecule of FMN is the same as that of FR, but that of FAD is only 9% of FR.
In the organs containing much FAD, such as heart, liver and retina, the fluorescence is esti mated to be too weak with the previous method.
Therefore the content of FAD was estimated by comparing the fluorescence intensity after conversion into FR with that before treatment. 
Liver:
Liver is the organ which contains the greatest amount of the vi tamin in the body.
In the untreated preparation, most vitamin fluorescence was seen in the acinus of the liver, especially in the peripheral part of the acinus rather than in the central part.
The fluorescence in the stellate cells was slight.
Among In untreated preparations, a weak fluorescence was seen in the anterior and posterior horn of the gray matter, but was absent in the white matter.
The fluorescence was not extracted by BzOH treatment, and slightly increased by phosphatase treatment, indicating that the distribution of the vitamin was very poor, occurring mainly in the anterior and posterior horn of the gray matter in the form of FAD.
Peripheral
Nerves:
No fluorescence was found in untreated prepa rations, and its intensification by phosphatase treatment was not marked.
Kidneys:
The kidney is one of the richest organs in riboflavin.
In un treated preparations, the fluorescence was relatively intense in renal tubules, especially in proximal tubules, whereas it was relatively poor in renal cor puscles as compared with that in tubules. These fluorescences remained un changed by BzOH treatment, but were slightly intensified in tubules and corpuscles by phosphatase treatment, indicating the presence of littile FR in renal tissues and a relatively much FAD in tubules and corpuscles.
Testes: A slight fluorescence was seen in seminal tubules, but none in interstitial tissues. BzOH treatment did not cause any change in the fluores cence, but phosphatase treatment caused a slight increase, suggesting the existance of FAD in seminal tubules.
Uterus:
The fluorescence is extremely poor except in the muscular layer, where a slight fluorescence was seen.
It was slightly intensified by phospha tase treatment, indicating the existence of FAD in the muscular layer.
Adrenals:
The adrenal glands are one of the richest organs in ribofla vin.
In the cortex, especially in zona fasciculata and reticularis, the fluores cence is very intense.
In the medulla it was slightly seen only in the surroundings of blood vessels. These fluorescences were slightly weakened by BzOH treatment in the cortex and were intensified by phosphatase treat ment, suggesting the existance of little FR and FMN and of much FAD in the cortex and the existance of little FAD around the blood vessels in medul la.
Skeletal
Muscles:
In untreated preparations the fluorescence was slightly seen in muscular bundles, but scarcely seen in intersitial tissues. It remained unchanged after BzOH treatment, but was increased by phosphatase treatment, indicating the existence of relatively much FAD in muscular bun dles.
Eye-balls:
The fluorescence wassc arcely seen in the cornea and sclera, but slightly in the chorioidea and retina. 
Group of Oral Administration of Riboflavin
Stomach: After loading with FR, the fluorescence was slightly enhanced in the mucosa, but was reduced by BzOH treatment.
Phosphatase treatment did not show any difference from the normal group.
After loading with FMN, the fluorescence was slightly increased in the mucosa and mucous layer. No change was observed by both BzOH and phosphatase treatments, indicating a slight absorption of FMN from the stomach.
In the group loaded with FAD, the fluorescence was scarcely different from normal animals, indicating the failure of FAD absorption.
Small
Intestine:
In the group loaded with FR, a definite increase of the fluorescence was seen in the mucous and submucous tissue, but not in the serous and muscular layer. The fluorescence in mucous epithelia was reduced by BzOH treatment but it remained unchanged in the mucous and submucous tissue. Phosphatase treatment caused no change from the un loaded group.
Thus FR is considered to be absorbed as FR through the mucous epithelia, but to be changed into FMN in the mucous layer.
In the group loaded with FMN an increase of the fluorescence was found in mucous epithelia, mucous layer and submucous tissue, but no change was observed by BzOH treatment.
Thus it is considered that the FMN administered is well absorbed as FMN from the mucous membrane of the small intestine. In the group loaded with FAD, the fluorescence was almost the same as that in the control group, but in this case the fluorescence was slightly increased by phosphatase treatment in the mucous and submucous tissues. It is suggest ed therefore that a small amount of FAD is absorbed from the mucous mem brane of the small intestine.
Large
In the group loaded with FR, a slight increase of the fluorescence was observed in the mucous layer, but there was no difference in the mucosa, muscular layer and serosa from that in the control group. After BzOH treatment, the fluorescence in the mucosa almost disappeared, but after phosphatase treatment, scarcely any change was found. Thus FR is considered not be converted to FMN after absorption from the large intestine, as is the case in the small intestine, but is absorbed as such, slightly increas ing the content of FRR in the mucosa.
In the group loaded with FMN, a slight increase of the fluorescence was observed in the mucous and submucous tissue, but no change was seen after treatment with BzOH and phosphatase. In the serous and muscular layer, the fluorescence intensity was almost the same as that of the unloaded group.
In other words, in the group loaded with FMN, increase of FMN was observed in the mucous and submucous layer, indicating the absorption of FMN from the large intestine.
In the group loaded with FAD, the fluorescence of each layer was almost the same as that of the unloaded group, suggesting the failure of absorption of FAD from the large intestine.
Liver:
In the group loaded with FR, a definite increase of the fluorescence in liver and stellate cells. It was hardly affected by BzOH treatment, but was markedly intensified by phosphatase treatment, showing that the loaded FR was converted to FAD in the liver (Figs. 5 and 6 ).
In the group loaded with FMN, a definite increase of the fluorescence was also observed especially in both liver and stellate cells. This fluorescence was almost unaffected by BzOH treatment, but intensified by phosphatase treatment. Namely, in crease of both FAD and FMN was confirmed after loading with FMN.
In the group loaded with FAD, increase of fluorescence was slight, but after phosphatase treatment it was markedly intensified. Thus in the group load ed with FAD, FAD was found to increase in the liver.
Pancreas:
No increase of the fluorescence was seen following the oral administration of FR, FMN and FAD, respectively.
Heart: In the group loaded with FR, a slight increase of the fluorescence was seen in the myocardium.
It was slightly reduced by BzOH treatment, but slightly increased after phosphatase treatment, indicating a slight increase of FR, FMN, and FAD in the myocardium after loading with FR.
In the group loaded with FMN, the fluorescence was slightly increased in the myo cardium.
It was not affected by BzOH treatment, but somewhat intensified by phosphatase treatment, showing the increase in FMN and FAD in the myocardium after loading with FMN. In untreated preparations of the group loaded with FAD, scarcely any increase in fluorescence intensity was noted, but it was intensified in the myocardium after phosphatase treatment. It suggests that after loading with FAD, a very small amount of FAD was in-creased in the myocardium.
Kidneys:
In the group loaded with FR, a marked increase of the fluores cence was seen in tubules, especially in proximal parts and a slight increase in corpuscles (Figs. 7 and 8) . It was slightly reduced by the BzOH treat ment, but scarcely affected by phosphatase treatment showing that in the group loaded with FR, increase of both FR and FMN was found in the pro ximal tubules and corpuscles, but scarcely any increase of FAD was observed. In the group loaded with FMN, a marked increase of the fluorescence was found in the tubules and corpuscles.
It was slightly decreased by BzOH treatment, but a little intensified by phosphatase treatment, suggesting a mark ed increase of both FR and FMN, without any change in FAD.
Increase of FR is possibly due to conversion of FMN into FR in the kidneys.
In the group loaded with FAD no significant increase of the total fluorescence was observed compared with those loaded with FMN, but a slight increase of FAD was found.
Other
Organs:
No marked increase was seen in other organs except for the retina.
In the latter tissue, increase of the fluorescence after phos phatase treatment was noted in the group loaded with FR or FMN, indicating the increase of FAD.
Group of Riboflavin Injection
Stomach:
Almost no change in fluorescence was found in the group loaded with FR, FMN or FAD.
Small
In the group loaded with FR, a slight increase of the fluorescence was seen in the mucosa, submucous tissue and muscular layer.
It was reduced by BzOH treatment, but almost unchanged after phos phatase treatment, indicating the increase of FR.
In the group loaded with FMN, a slight increase of the fluorescence was found in each layer of the intestine, whereas that in the mucous layer was slightly reduced by BzOH treatment but remained unchanged after phosphatase treatment. Namely, in the group loaded with FMN, a slight rise of FR in the mucous layer and that of FMN in other each layer were found.
In the group loaded with FAD, a slight increase of the fluorescence was seen in the muscular layer. It was almost unaffected by BzOH treatment, but was intensified by phosphatase treatment, indicating a slight rise of FAD in the muscular layer.
Large Intestine:
In the group loaded with FR, a slight increase of the fluorescence was found in the mucosa and submucous tissue, but it was reduced by BzOH treatment, and almost unchanged by phosphatase treatment indicating the increase of FR.
In the group loaded with FMN, the fluores cence was almost unchanged in the mucous and submucous tissue.
A slight fluorescence was seen in the muscular layer, but it was scarcely influenced by BzOH or phosphatase treatment.
In the group loaded with FAD, the fluorescence was slightly increased in the muscular layer, and intensified by phosphatase treatment. Liver:
In the group loaded with FR, increase of the fluorescence was generally remarkable, especially in the stellate cells. It was markedly re duced by BzOH treatment, and was intensified by phosphatase treatment, in dicating the definite rise of FR and a slight rise of both FMN and FAD.
In the group loaded with FMN, increase of the fluorescence was seen generally in the liver cells, but it was slmost unchanged by BzOH treatment, showing the increase of both FMN and FAD.
In the untreated preparations of the group loaded with FAD, the increase was not remarkable, but was markedly increased by phosphatase treatment, suggesting a definite rise of FAD.
Pancreas:
In each case loaded with FR, FMN and FAD, respectively, a slight rise of the fluorescencence was noted.
No change was seen in the endocrine portion, but a slight rise of the fluorescence was observed in the exocirne portion.
Heart:
In the group loaded with FR, a slight increase of the fluorescence was seen in the myocardium.
It was somewhat reduced by BzOH treatment, and rose slightly by phosphatase treatment, indicating the slight increase of FR, FMN and FAD.
In the group loaded with FMN, the fluorescence was increased in the myocardium.
It was almost unchanged by BzOH treatment, but was increased by phosphatase treatment, showing the rise of both FMN and FAD.
In the group loaded with FAD, a small amount of the fluores cence was increased and was intensified by phosphatase treatment, indicating a slight rise of FAD in the myocardium.
Kidneys:
In the group loaded with FR, a marked increase of the fluores cence was seen in the glomeruli and tubules. It was definitely reduced by BzOH treatment, but the rise of the fluorescence by phosphatase treatment was not marked, showing the definite rise of FR.
In the group loaded with FMN, the rise of the fluorescence in the tubules and glomeruli was remark able.
It was not affected by BzOH treatment and was slightly increased by phosphatase treatment.
In the group loaded with FAD, the change of the fluorescence was largely the same as that loaded with FMN, but the increase of the fluorescence by phosphatase treatment was a little more marked, in dicating the more increase of FAD in the kidneys than that loaded with FMN. Other Organs:
No marked increase in the fluorescence was noted. After loading with FR, a slight rise in the fluorescence was seen in the cho rioidea and retina of the eye-ball.
It was decreased by BzOH treatment. In both the groups loaded with FMN or FAD, no marked increase of the fluo rescence was observed.
Riboflavin Distribution in the Rats Poisoned with CCl4
The change of the liver poisoned with CCl4 vary individually, but gener ally characterized by remarkable congestion, cloudy swelling and appearance of small vacuoles in the liver cells, and necrosis, especially in the central parts of the acini.
The lesions caused in other organs were remarkable con gestion and degeneration of parenchymatous tissues.
In the small intestine, slight congestion, degeneration and desquamation of mucous epithelia were found.
In the kidneys, congestion and cloudy swelling of the tubules were seen. In the spleen, congestion and necrosis of the medulla; in the heart, congestion was also observed.
Small
In the untreated preparations, the fluorescence was generally weaker than that of the normal rat, especially in the area, where drastic changes such as degeneration and desquamation of mucous epithelia took place.
The decrease of the fluorescence by BzOH treatment was not so different from the control animals, but it was slightly weaker than that of the normal animals after BzOH treatment and was scarcely affected by phos phatase treatment, indicating that in the small intestine of the poisoned ani mal, FR and FAD were extremely poor, with a slight amount of FMN. In the group loaded with FR, the fluorescence was strong, but it largely disap peared after BzOH treatment, especially in the portion of desquamative de generation.
Intensification of the fluorescence by phosphatase treatment was scarcely observed.
In the group loaded with FMN, the fluorescence was more intense than that after loading with FR, but much less than that in the in the control group.
No increase of the fluorescence by phosphatase treat ment was detected.
In the group loaded with FAD, the fluorescence was almost the same as that without loading, but it increased a little after treat ment with phosphatase, indicating that the increase of FAD was slightly more than the cases after loading with FR or FMN.
Liver:
No fluorescence was seen in the cells of the central parts of acini, showing marked necrosis and fatty degeneration, but a weak fluorescence was observed in the paripheral parts of acini showing insignificant histological change and in blood vessels.
It was intensified by phosphatase treatment, though much weaker than that in normal animals.
FAD is therefore consi dered to be much less than in normal animals.
In the group loaded with FR, the fluorescence was seen in the cells near blood vessels. It was de creased by BzOH treatment and increased by phosphatase treatment showing the rise of both FR and FAD in the cells around blood vessels.
After injec tion of FR, the rise of the fluorescence and its fall by BzOH treatment were more marked than after oral administration.
However, the rise of the fluo rescence by phosphatase treatment was less than after oral administration. It shows that after injection of the vitamin the rise of FR was more marked than after oral administration, but the rise of FAD was less.
In the group loaded with FMN, after both oral and subcutaneous administration, increase of the fluorescence around blood vessels was seen. It was scarcely reduced by BzOH treatment, but definitely intensified by phosphatase treatment, indicat ing the presence of little FR and much FAD.
In the group loaded with FAD, after both oral and subcutaneous administration, increase of the fluores cence appeared in the surroundings of blood vessels. After phosphatase treatment, intensification of the fluorescence was observed even up to the por tion with relatively slight pathological changes.
In any case, the rise of the fluorescence was more marked in the injected group than that of the oral group (Figs. 9-12 ).
Kidneys:
The fluorescence was very weak in the kidneys of the poison- After loading with FMN, the absorption seemed to be somewhat better than the case with FR. After subcutaneous injection, scarcely any change was observed.
In the liver, de crease of FR was as marked as in the small intestine, and the vitamin occur mostly in the form of FMN and FAD.
However, the fluorescence was barely detectable in the area of degeneration and necrosis. According to Watanabe (39) , the more the lesion in the liver, the lower the total riboflavin level, leading to as low as two-thirds of the normal, whereby no difference in ratio of each component of the vitamin was observed.
After loading with the vitamin, the vitamin level became lower with the progress of the disturbance, whereby FMN was relatively rather increased, FAD almost unchanged, and FR was without change.
Okubo (40) reported that most of the FR loaded did not move to the tissue, and after loading with FMN or FAD the total vitamin level rose only slightly.
In our experiment, the rise of the vita min level after oral administration of FR was not marked, whereas aftersub cutaneous injection the vitamin level rose, mostly in FR, in the surroundings of blood vessels, i.e., in the peripheral parts of the acini. With respect to the riboflavin content in the kidneys of the CC14-poisoned animal, Watanabe found scarcely any change biochemically from the normal. According to our experiment, the vitamin level in the poisoned kidneys was very low, especially in the damaged portion, but still a trace of both free and esterified riboflavin was proved in glomeruli and tubules.
After loading with FR, it slightly increased in tubules without any further changes. Okubo (40) observed that the urinary excretion of riboflavin in CC14-poisoned rabbits was decreased, and after loading with esterified form, the urinary excretion of esterified vitamin was increased.
In the heart muscle scarcely any change was observed in the vitamin level, in agreement with the report of Okubo (40) and Watanabe (39) . As stated above, in the CC14-poisoned rats, the level of riboflavin in tissues, such as the intestine, liver, kidneys, etc. was decreased, possibly due to the depression of absorption from the intestine and of phos phorylation, disturbance of renal reabsorption, and the decrease of the thresh old for passage of the esterified vitamin.
SUMMARY
The authors improved the histochemical method for riboflavin, devised a phos phatase method, and established the principle of separate observation of the three forms of riboflavin.
Using this method, histological distribution of ri boflavin in normal and CC14-poisoned rats was observed.
Furthermore, the fate of the three forms of riboflavin after loading with riboflavin (FR), flavin mononucleotide (FMN) and flavin-adenine dinucleotide (FAD) was studied with the following results.
1. To extract riboflavin histochemically, benzyl alcohol treatment is the most suitable.
2. For converting the esterified riboflavin into the free form, the enzymatic method using phosphatase is the most adequate. 3. Riboflavin occurs widely in the animal body, mostly in the esterified form, especially FAD. However, the distribution varies according to the organs.
4. Riboflavin is absorbed largely from the small intestine, whereby it is phosphorylated into FMN in the mucous epithelia, and is transferred to the liver to be converted into FAD.
5. After oral administration of free vitamin, the rise of the levels of each component of the vitamin is observed in the body.
After loading with FMN, the levels of both FMN and FAD is increased, whereas after loading with FAD, only a slight amount of FAD was observed.
6. After injection of FR, increase of FR is observed without any change of FMN and FAD.
After injection of FMN, both FMN and FAD were in creased in the body but after injection of FAD, a slight amount of FR was increased in the mucous layer of intestinal mucosa, and in other tissues FAD was increased.
7. In the CC14-poisoned rats, decrease of the esterified form of the vitamin was generally seen.
After loading with the vitamin, depression of absorp tion and phosphorylation of the vitamin was noted .
